Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,960 public trials 1,827 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

NCT07277231

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • Northwestern University Chicago, Illinois, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • Blacktown Cancer and Haematology Centre Blacktown, New South Wales, Australia
View all 91 locations
View Trial Details
Recruiting

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

NCT07069699

Conditions
Burkitt Lymphoma, DNA Virus Infections, Double-Expressor Lymphoma, +16 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of Kansas Clinical Research Center Fairway, Kansas, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
View Trial Details
Recruiting

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

NCT06091865

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • University of California Irvine Medical Center Orange, California, United States
  • University of California (UC) Davis Sacramento, California, United States
View all 168 locations
View Trial Details
Recruiting

Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia

NCT06965114

Conditions
Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • NCI - Center for Cancer Research Bethesda, Maryland, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
  • University of Virginia Cancer Center Charlottesville, Virginia, United States
View Trial Details
Recruiting

Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)

NCT06160791

Conditions
Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytoses, Histiocytosis, +3 more
Locations
  • University of California, Irvine Irvine, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View Trial Details
Recruiting

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

NCT06846671

Conditions
CLL, Chronic Disease, Chronic Lymphocytic Leukemia, +15 more
Locations
  • St Bernards Medical Center Jonesboro, Arkansas, United States
  • UCLA Department of Medicine Hematologyoncology Los Angeles, California, United States
  • Pih Health Whittier Hospital Whittier, California, United States
  • Rocky Mountain Cancer Centers (Williams) Usor Aurora, Colorado, United States
View all 124 locations
View Trial Details
Recruiting

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

NCT06072131

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of California, San Francisco Fresno Clovis, California, United States
  • University of California, Los Angeles Hem/ Onc Clinical Research Unit, Suite 600 Santa Monica, California, United States
  • University of Colorado School of Medicine Aurora, Colorado, United States
  • Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System Memorial Cancer Institute Pembroke Pines, Florida, United States
View all 69 locations
View Trial Details

Related conditions